Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals stock analysis and opportunity scoring
$3.44
↓ -1.43%
Recursion Pharmaceuticals (RXRX) at a glance
Recursion Pharmaceuticals (RXRX) is a publicly traded company tracked by MKD Intelligence.
RXRX last traded at $2.96 as of 2026-08-28.
MKD Intelligence assigns RXRX a composite opportunity score of 60 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for RXRX is 75 out of 100 (high), where a higher number means greater expected volatility.
Price History
High
$3.56
Low
$2.96
Period
Aug 27 - Jul 24 (25d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Aug 28
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.